UK Research Ethics Committee’s review of the global first SARS-CoV-2 human infection challenge studies
Other content recommended for you
- Controlled human infection with SARS-CoV-2 to study COVID-19 vaccines and treatments: bioethics in Utopia
- Do coronavirus vaccine challenge trials have a distinctive generalisability problem?
- COVID-19 controlled human infection studies: worries about local community impact and demands for local engagement
- Covid-19 vaccines: Should we allow human challenge studies to infect healthy volunteers with SARS-CoV-2?
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- Why continuing uncertainties are no reason to postpone challenge trials for coronavirus vaccines
- Investigating Bordetella pertussis colonisation and immunity: protocol for an inpatient controlled human infection model
- Controlled human infection with Neisseria lactamica in late pregnancy to measure horizontal transmission and microbiome changes in mother–neonate pairs: a single-arm interventional pilot study protocol
- Uncertainty, error and informed consent to challenge trials of COVID-19 vaccines: response to Steel et al
- Ethical guidelines for deliberately infecting volunteers with COVID-19